Understanding the Common Side Effects of Semaglutide: What You Need to Know

Semaglutide has transformed weight loss therapy for thousands of people, but like all medications, it can trigger unwanted reactions during the first weeks of treatment. Knowing which side effects are common, how long they typically last, and what management strategies work best prepares you to navigate your treatment journey successfully.

What Is Semaglutide and How Does It Work?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. When you take semaglutide, it slows stomach emptying, increases feelings of fullness, and helps regulate appetite signals in your brain. This triple action makes you eat less without the constant hunger that often derails traditional diets.

The STEP clinical trials demonstrated that patients taking semaglutide achieved significant weight reduction compared to placebo groups. PlexusDx offers compounded semaglutide injections starting at $179 per month from licensed 503A compounding pharmacies, plus oral formulations beginning at $209 monthly. Both delivery methods activate the same biological pathways, though some patients tolerate one form better than the other.

Because semaglutide works through hormonal and digestive mechanisms, your gastrointestinal system often needs time to adjust. This adjustment period typically produces the side effects discussed below, most of which resolve within the first 4 to 8 weeks as your body acclimates to the medication.

Nausea: The Most Common Semaglutide Side Effect

Nausea ranks as the most frequently reported side effect during semaglutide treatment, affecting approximately 25 to 40 percent of patients in early treatment phases. The sensation usually emerges within the first few days of starting the medication and gradually improves as your digestive system adapts over several weeks.

To minimize nausea, eat smaller meals throughout the day instead of three large ones, avoid greasy or heavily spiced foods, stay hydrated with water and electrolyte beverages, and take your dose in the evening when you can rest afterward. Ginger tea, peppermint, and slow, deliberate eating help many patients. If nausea persists beyond 6 weeks or becomes severe, contact your healthcare provider—they may recommend dose timing adjustments or temporary anti-nausea medication while you acclimate.

Interestingly, nausea often serves as a signal that semaglutide is working effectively. The sensation indicates your appetite pathways are responding to the medication, which typically correlates with better weight loss outcomes. This understanding helps reframe the side effect as evidence of progress rather than a problem.

Diarrhea: Managing Changes in Bowel Habits

Diarrhea affects roughly 20 to 30 percent of semaglutide users, particularly during the dose escalation phase. Your body experiences loose or frequent stools because semaglutide alters how quickly food moves through your intestines and influences bacterial composition in your gut microbiome.

Dietary adjustments resolve most diarrhea episodes without medication: increase soluble fiber intake through oats, apples, and beans; drink plenty of clear fluids to prevent dehydration; avoid high-fat foods and excess sugar; and eat slowly to allow better digestion. Over-the-counter loperamide (Imodium) or bismuth subsalicylate (Pepto-Bismol) can provide temporary relief, but consult your doctor before using these products. Most patients find that diarrhea diminishes significantly after 4 to 6 weeks as their microbiota rebalance.

Probiotics and fermented foods like yogurt, kefir, and sauerkraut support healthy gut bacteria during this transition. Tracking which foods trigger loose stools helps you identify personal triggers and adjust your diet accordingly. Diarrhea typically resolves completely, though staying hydrated throughout treatment remains important.

Vomiting: When It Occurs and How to Respond

Vomiting occurs less frequently than nausea, affecting roughly 5 to 10 percent of semaglutide patients, usually during the initial two weeks of treatment or after dose increases. Unlike nausea, which many patients learn to tolerate, vomiting requires immediate attention because it can lead to dehydration and electrolyte imbalances.

If you experience vomiting, stop eating solid foods temporarily and focus on clear liquids—water, bone broth, coconut water, and diluted fruit juice—consumed in small sips every 15 to 20 minutes. Contact your prescribing provider if vomiting occurs more than twice in a single day, lasts longer than a few hours, or is accompanied by severe abdominal pain or dizziness. Your doctor may recommend taking your next dose at a different time, temporarily pausing treatment, or using prescription anti-nausea medication until symptoms resolve. Vomiting that continues beyond the first week warrants professional evaluation to rule out other causes.

Abdominal Pain and Cramping: Distinguishing Normal Discomfort

Mild to moderate abdominal discomfort affects approximately 15 to 20 percent of semaglutide patients during the adjustment phase. This cramping typically results from altered intestinal motility and usually feels like general stomach tenderness rather than sharp, localized pain.

Heat application, such as a heating pad on your abdomen for 10 to 15 minutes, provides relief for most cramping episodes. Gentle movement, slow walking, and light stretching also ease tension. Ensure you're drinking adequate water and eating regularly—sometimes cramping intensifies when the stomach is empty or dehydrated. However, severe, persistent, or worsening abdominal pain; pain accompanied by fever; or pain that radiates to your back requires immediate medical evaluation, as these symptoms could indicate a different condition unrelated to semaglutide.

Working with your prescriber to adjust meal timing and composition often eliminates cramping entirely. Some patients find that taking semaglutide at a different time of day or with specific foods reduces discomfort. These adjustments should always occur under medical guidance.

Constipation: A Less Expected but Important Side Effect

While diarrhea receives more attention, constipation affects 15 to 25 percent of semaglutide patients, particularly after the first 4 to 6 weeks when the initial diarrhea phase resolves. Constipation develops because semaglutide slows intestinal movement overall, and some people's systems respond by slowing too much.

Increase dietary fiber gradually by eating leafy greens, whole grains, legumes, berries, and seeds while simultaneously increasing water intake—aim for at least 8 to 10 glasses daily. Physical activity, especially walking 20 to 30 minutes after meals, stimulates bowel movement through natural mechanisms. Over-the-counter stool softeners like docusate or osmotic laxatives like polyethylene glycol (MiraLAX) offer safe temporary relief. Avoid stimulant laxatives unless your doctor specifically recommends them, as overuse can reduce their effectiveness.

Magnesium supplementation, often available at 200 to 400 milligrams daily, addresses constipation while supporting overall health. Many patients successfully manage constipation through consistent hydration, adequate fiber, and regular movement without needing medication. If constipation persists despite these measures or causes severe discomfort, discuss alternative timing or formulations with your provider.

Frequently Asked Questions About Understanding the Common Side Effects of Semaglutide: What You Need to Know

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.